Calcineurin phosphatase activity and immunosuppression. A review on the role of calcineurin phosphatase activity and the immunosuppressive effect of cyclosporin A and tacrolimus

Scandinavian Journal of Immunology

Volumn 57, Issue 2, 2003, Pages 93-98

  Jorgensen K A ^a   Koefoed Nielsen, P B ^a   Karamperis, N ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN PHOSPHATASE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; PHOSPHATASE; TACROLIMUS; UNCLASSIFIED DRUG;

DRUG EFFECT; DRUG ISOLATION; DRUG RECEPTOR BINDING; DRUG UPTAKE; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; PRIORITY JOURNAL; PROTEIN FOLDING; REVIEW; T LYMPHOCYTE ACTIVATION;

AMINO ACID SEQUENCE; CYCLOSPORINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MOLECULAR SEQUENCE DATA; PHOSPHORIC MONOESTER HYDROLASES; TACROLIMUS; TRANSPLANTATION IMMUNOLOGY;

EID: 0037323992     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2003.01221.x     Document Type: Review

References (52)

1. Klee C, Crouch TH, Krinks MH. Calcineurin: a calcium - calmodulin-binding protein of the nervous system. Proc Natl Acad Sci USA 1979;76:6270-3.
2. Klee CB, Draetta GF, Hubbard MJ. Calcineurin. In: Meister A, ed. Advances in Enzymology and Related Areas of Molecular Biology, Vol. 61. New York: Wiley, 1988, 149-209.
3. Borel JF. Comparative study of in vitro and in vivo drug effects on cell mediated cytotoxicity. Immunology 1976;31:631-41.
4. Handschumacher RE, Harding MW, Rice J, Drugge RJ. Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science 1984;226:544-7.
5. Fischer G, Bang H, Mech C. Nachweis einer Enzymkatalyse für die cis - trans-isomerisierung der peptidbindung in ptolinhaltigen peptiden. Biochim Biophys Acta 1984;43:1101-11.
6. Fischer G, Bang H. The refolding of urea-denaturated ribonuclease A is catalyzed by peptidyl - propyl cis - trans isomerase. Biochim Biophys Acta 1985;828:39-42.
7. Fischer G, Wittmann-Liebold K, Lang K, Kiefhaber T, Schmid FX. Cyclophilin and peptidyl - propyl cis - trans isomerase are probably identical proteins. Nature 1989;337:476-8.
8. Takahashi N, Hayano T, Suzuki M. Peptidyl - propyl cis - trans isomerase is cyclosporln A-binding protein cyclophilin. Nature 1989;337:473-5.
9. Kino T, Hatanaka H, Hashimoto H et al. FK-506, a novel immuno-suppressant isolated from a Streptomyces. I. Fermentation, isolation, and physicochemical and biological characteristics. J Antibiot 1987;40:1249-55.
10. Tanaka H, Kuroda A, Marusawa H et al. Physicochemical properties of FK-506, a novel immunosuppressant isolated from Streptomyces tsukubaensis. Transplant Proc 1987;19:s11-6.
11. Harding MW, Galat A, Uehling DE, Schreiber SL. A receptor for the immunosuppressant FK506 is a cis - trans peptidyl - propyl isomerase. Nature 1989;341:758-60.
12. Cardenas ME, Zhu D, Heitman J. Molecular mechanisms of immuno-suppression by cyclosporine, FK506, and rapamycin. Curr Opin Nephrol Hypertens 1995;4:472-7.
13. Mattila PS, Ullman KS, Fiering S et al. The actions of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes. EMBO J 1990;9:4425-33.
14. Bierer BE, Mattila PS, Standaert RF et al. Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin. Proc Natl Acad Sci USA 1990;87:9231-5.
15. Liu J, Farmer JD, Lane WS, Friedman J, Weissman I, Schreiber SL. Calcineurin is a common target of cyclophilin cyclosporin A and FKBP-FK506 complexes. Cell 1991;66:807-15.
16. Friedman J, Weissman I. Two cytoplasmatic candidates for immunophilin action are revealed by affinity for a new cyclophilin: one in the presence and one in the absence of CsA. Cell 1991;66:799-806.
17. Husi H, Luyten MA, Zurini MGM. Mapping of the immunophilin-immunosuppressant site of interaction of calcineurin. J Biol Chem 1994;14:199-204.
18. Liu J, Albers MW, Wandless TJ et al. Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity. Biochemistry 1992;31:3896-901.
19. O'Keefe SJ, Tamura JI, Kincaid RL, Tocci MJ, O'Neill EA. FK-506- and CsA-sensitive activation of the interleukin-2 promotor by calcineurin. Nature 1992;357:692-4.
20. Clipstone NA, Crabtree GR. Identification of calcineurin as a key signaling enzyme in T-lymphocyte activation. Nature 1992;357:695-7.
21. Griffith JP, Kim JL, Kim EE et al. X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex. Cell 1995;82:507-22.
22. Kissinger CR, Parge HE, Knighton DR et al. Crystal structure of human calcineurin and human FKBP12-FK506-calcineurin complex. Nature 1995;378:641-4.
23. Crabtree GR. Contigent genetic regulatory events in T lymphocyte activation. Science 1989;243:355-61.
24. Shaw J-P, Utz PJ, Durand DB, Toole JJ, Emmel EA, Crabtree GR. Identification of a putative regulator of early T cell activation genes. Science 1988;243:202-5.
25. Flanagan WM, Corthésy B, Bram RJ, Crabtree G. Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporine A. Nature 1991;352:803-7.
26. Jain J, McCaffrey PG, Valge-Archer VE, Rao A. Nuclear factor of activated T-cells contains Fos and Jun. Nature 1992;356:801-4.
27. p is a substrate for calcineurin and interacts with Fos and Jun. Nature 1993;365:352-5.
28. p, a T lymphocyte DNA binding protein that is a target of for calcineurin and immunosuppressive drugs. J Biol Chem 1993;268:3747-52.
29. p polyclonal antibody. J Biol Chem 1995;270:22602-7.
30. Shaw KT-Y, Ho AM, Raghaven AJ et al. Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells. Proc Natl Acad Sci USA 1995;92:11205-9.
31. Loh C, Shaw KT-Y, Carew J et al. Calcineurin binds transcription factor NFAT1 and reversibly regulates its activity. J Biol Chem 1996;271:10884-91.
32. p inhibits its DNA binding activity in cyclosporin A-treated human B and T cells. J Biol Chem 1995;270:20653-9.
33. Shibasaki F, Price ER, Milan D, McKeon F. Role of kinases and phosphatase calcineurin in the nuclear shuttling of transcription factor NF-AT4. Nature 1996;382:370-3.
34. c enhanced by glycogen synthase kinase-3. Science 1997;275:1930-3.
35. Rusnak F, Mertz P. Calcineurin: form and function. Physiol Rev 2000;80:1483-521.
36. Shibasaki F, Hallin U, Uchino H. Calcineurin as a multifunctional regulator. J Biochem 2002;131:1-15.
37. Myers BD, Newton L. Cyclosporine-induced chronic nephropathy: an obliterative microvascular renal injury. J Am Soc Nephrol 1991;2:s45-52.
38. Dantal J, Hourmant M, Cantarovich D et al. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimes. Lancet 1998;351:623-8.
39. Fruman DA, Klee CB, Bierer BE, Burakoff SJ. Calcineurin phosphatase activity in T-lymphocytes is inhibited by FK 506 and cyclosporin A. Proc Natl Acad Sci USA 1992;89:3686-90.
40. Hubbard M, Klee CB. Exogenous kinases and phosphatases as probes of intracellular modulation. In: Chad J, Wheal H, eds. Molecular Neurobiology. Oxford, UK: Oxford University, 1991, 135-51.
41. Batuik TD, Padzerka F, Halloran P. Calcineurin activity is only partially inhibited in leukocytes of cyclosporine-treated patients. Transplantation 1995;59:1400-4.
42. Batuik TD, Pazderka F, Enns J, Decastro L, Halloran P. Cyclosporine inhibition of calcineurin activity in human leukocytes in vivo is rapidly reversible. J Clin Invest 1995;96:1254-60.
43. Piccini G, Gaspari F, Signorini O, Remuzzi G, Perico N. Recovery of blood mononuclear cell calcineurin activity segregates two populations of renal transplant patients with different sensitivities to cyclosporine inhibition. Transplantation 1996;61:1526-31.
44. Caruso R, Perico N, Cattaneo D et al. Whole-blood calcineurin activity is not predicted by cyclosporine blood concentration in renal transplant patients. Clin Chem 2001;47:1679-87.
45. Halloran PF, Helms LMH, Kung L, Noujaim J. The temporal profile of calcineurin inhibition by cyclosporine in vivo. Transplantation 1999;68:1356-61.
46. Kung L, Halloran PF. Immunophilins may limit calcineurin inhibition by cyclosporine and tacrolimus at high drug concentrations. Transplantation 2000;70:327-35.
47. Kung L, Batuik TD, Palomo-Pinon S, Noujaim J, Helms LMH, Halloran P. Tissue distribution of calcineurin and its sensitivity to inhibition by cyclosporine. Am J Transplant 2001;1:325-33.
48. Pai S-Y, Fruman DA, Leong T et al. Inhibition of calcineurin phosphatase in adult bone marrow transplant patients treated with cyclosporine A. Blood 1994;84:3974-9.
49. Koefoed-Nielsen PB, Gesualdo MB, Poulsen JH, Jørgensen KA. Blood tacrolimus levels and calcineurin phosphatase activity early after renal transplantation. Am J Transplant 2002;2:173-8.
50. Lane BC, Miller LN, Or Y-S, Weidemann P, Luly JR. Evaluation of calcineurin's role in the immunosuppressive activity of FK 506, related macrolactams, and cyclosporine. Transplant Proc 1993;25:644-6.
51. Mitsuhashi S, Shima H, Kikuchi K et al. Development of an assay method for activities of serine/threonine protein phosphatase type 2B (calcineurin) in crude extracts. Anal Biochem 2000;278:192-7.
52. Gesulado M, Koefoed-Nielsen PB, Jørgensen KA. "In Vitro" inhibition of calcineurin phosphatse by cyclosporine and tacrolimus and their immunophilins. Am J Respir Crit Care Med 2001;163:A341 (Abstract).